Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial Article Swipe

PDF

Domenica Lorusso , Marie‐Ange Mouret‐Reynier , Philipp Harter , Claire Cropet , Cristina Caballero , P Wolfrum-Ristau , Toyomi Satoh , Ignace Vergote , Gabriella Parma , Trine Jakobi Nøttrup , Coriolan Lebreton , Peter A. Fasching , Carmela Pisano , Luís Manso , Hugues Bourgeois , Ingo B. Runnebaum , Claudio Zamagni , Anne‐Claire Hardy‐Bessard , Andreas Schnelzer , Michel Fabbro , Barbara Schmalfeldt , Dominique Berton , Antje Belau , Jean‐Pierre Lotz , Martina Gropp‐Meier , Laurence Gladieff , Hans‐Joachim Lück , Sophie Abadie‐Lacourtoisie , Éric Pujade-Lauraine , Isabelle Ray‐Coquard ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1136/ijgc-2023-004995

This post hoc analysis indicates that in patients with newly diagnosed advanced HRD-positive ovarian cancer, maintenance olaparib plus bevacizumab should not be limited to those considered at higher risk of disease progression. Five-year progression-free survival rates support long-term remission and suggest an increased potential for cure with particular benefit suggested in lower-risk HRD-positive patients.

Related Topics

Reverse Transcription Polymerase Chain Reaction

Chemistry

Biochemistry

Concepts

Medicine Olaparib Bevacizumab Ovarian cancer Oncology Internal medicine Overall survival Progression-free survival Maintenance therapy Cancer Chemotherapy Gene Poly ADP ribose polymerase Polymerase Chemistry Biochemistry

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1136/ijgc-2023-004995
PDF: https://ijgc.bmj.com/content/ijgc/early/2023/12/21/ijgc-2023-004995.full.pdf
OA Status: hybrid
Cited By: 42
References: 24
Related Works: 10
OpenAlex ID: https://openalex.org/W4390078374

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4390078374

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1136/ijgc-2023-004995

Digital Object Identifier
Title: Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-12-22

Full publication date if available
Authors: Domenica Lorusso, Marie‐Ange Mouret‐Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, P Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine Jakobi Nøttrup, Coriolan Lebreton, Peter A. Fasching, Carmela Pisano, Luís Manso, Hugues Bourgeois, Ingo B. Runnebaum, Claudio Zamagni, Anne‐Claire Hardy‐Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean‐Pierre Lotz, Martina Gropp‐Meier, Laurence Gladieff, Hans‐Joachim Lück, Sophie Abadie‐Lacourtoisie, Éric Pujade-Lauraine, Isabelle Ray‐Coquard

List of authors in order
Landing page: https://doi.org/10.1136/ijgc-2023-004995

Publisher landing page
PDF URL: https://ijgc.bmj.com/content/ijgc/early/2023/12/21/ijgc-2023-004995.full.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://ijgc.bmj.com/content/ijgc/early/2023/12/21/ijgc-2023-004995.full.pdf

Direct OA link when available
Concepts: Medicine, Olaparib, Bevacizumab, Ovarian cancer, Oncology, Internal medicine, Overall survival, Progression-free survival, Maintenance therapy, Cancer, Chemotherapy, Gene, Poly ADP ribose polymerase, Polymerase, Chemistry, Biochemistry

Top concepts (fields/topics) attached by OpenAlex
Cited by: 42

Total citation count in OpenAlex
Citations by year (recent): 2025: 31, 2024: 11

Per-year citation counts (last 5 years)
References (count): 24

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4390078374
doi	https://doi.org/10.1136/ijgc-2023-004995
ids.doi	https://doi.org/10.1136/ijgc-2023-004995
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/38129136
ids.openalex	https://openalex.org/W4390078374
fwci	20.11995055
mesh[0].qualifier_ui
mesh[0].descriptor_ui	D005260
mesh[0].is_major_topic	False
mesh[0].qualifier_name
mesh[0].descriptor_name	Female
mesh[1].qualifier_ui
mesh[1].descriptor_ui	D006801
mesh[1].is_major_topic	False
mesh[1].qualifier_name
mesh[1].descriptor_name	Humans
mesh[2].qualifier_ui
mesh[2].descriptor_ui	D000068258
mesh[2].is_major_topic	False
mesh[2].qualifier_name
mesh[2].descriptor_name	Bevacizumab
mesh[3].qualifier_ui	Q000188
mesh[3].descriptor_ui	D000077216
mesh[3].is_major_topic	False
mesh[3].qualifier_name	drug therapy
mesh[3].descriptor_name	Carcinoma, Ovarian Epithelial
mesh[4].qualifier_ui	Q000473
mesh[4].descriptor_ui	D010051
mesh[4].is_major_topic	True
mesh[4].qualifier_name	pathology
mesh[4].descriptor_name	Ovarian Neoplasms
mesh[5].qualifier_ui
mesh[5].descriptor_ui	D010793
mesh[5].is_major_topic	False
mesh[5].qualifier_name
mesh[5].descriptor_name	Phthalazines
mesh[6].qualifier_ui
mesh[6].descriptor_ui	D010879
mesh[6].is_major_topic	True
mesh[6].qualifier_name
mesh[6].descriptor_name	Piperazines
mesh[7].qualifier_ui
mesh[7].descriptor_ui	D000077982
mesh[7].is_major_topic	False
mesh[7].qualifier_name
mesh[7].descriptor_name	Progression-Free Survival
mesh[8].qualifier_ui
mesh[8].descriptor_ui	D006801
mesh[8].is_major_topic	False
mesh[8].qualifier_name
mesh[8].descriptor_name	Humans
mesh[9].qualifier_ui
mesh[9].descriptor_ui	D005260
mesh[9].is_major_topic	False
mesh[9].qualifier_name
mesh[9].descriptor_name	Female
mesh[10].qualifier_ui
mesh[10].descriptor_ui	D000068258
mesh[10].is_major_topic	False
mesh[10].qualifier_name
mesh[10].descriptor_name	Bevacizumab
mesh[11].qualifier_ui
mesh[11].descriptor_ui	D000077982
mesh[11].is_major_topic	False
mesh[11].qualifier_name
mesh[11].descriptor_name	Progression-Free Survival
mesh[12].qualifier_ui	Q000473
mesh[12].descriptor_ui	D010051
mesh[12].is_major_topic	True
mesh[12].qualifier_name	pathology
mesh[12].descriptor_name	Ovarian Neoplasms
mesh[13].qualifier_ui	Q000188
mesh[13].descriptor_ui	D000077216
mesh[13].is_major_topic	False
mesh[13].qualifier_name	drug therapy
mesh[13].descriptor_name	Carcinoma, Ovarian Epithelial
mesh[14].qualifier_ui
mesh[14].descriptor_ui	D010793
mesh[14].is_major_topic	False
mesh[14].qualifier_name
mesh[14].descriptor_name	Phthalazines
mesh[15].qualifier_ui
mesh[15].descriptor_ui	D010879
mesh[15].is_major_topic	True
mesh[15].qualifier_name
mesh[15].descriptor_name	Piperazines
mesh[16].qualifier_ui
mesh[16].descriptor_ui	D005260
mesh[16].is_major_topic	False
mesh[16].qualifier_name
mesh[16].descriptor_name	Female
mesh[17].qualifier_ui
mesh[17].descriptor_ui	D006801
mesh[17].is_major_topic	False
mesh[17].qualifier_name
mesh[17].descriptor_name	Humans
mesh[18].qualifier_ui
mesh[18].descriptor_ui	D000068258
mesh[18].is_major_topic	False
mesh[18].qualifier_name
mesh[18].descriptor_name	Bevacizumab
mesh[19].qualifier_ui	Q000188
mesh[19].descriptor_ui	D000077216
mesh[19].is_major_topic	False
mesh[19].qualifier_name	drug therapy
mesh[19].descriptor_name	Carcinoma, Ovarian Epithelial
mesh[20].qualifier_ui	Q000473
mesh[20].descriptor_ui	D010051
mesh[20].is_major_topic	True
mesh[20].qualifier_name	pathology
mesh[20].descriptor_name	Ovarian Neoplasms
mesh[21].qualifier_ui
mesh[21].descriptor_ui	D010793
mesh[21].is_major_topic	False
mesh[21].qualifier_name
mesh[21].descriptor_name	Phthalazines
mesh[22].qualifier_ui
mesh[22].descriptor_ui	D010879
mesh[22].is_major_topic	True
mesh[22].qualifier_name
mesh[22].descriptor_name	Piperazines
mesh[23].qualifier_ui
mesh[23].descriptor_ui	D000077982
mesh[23].is_major_topic	False
mesh[23].qualifier_name
mesh[23].descriptor_name	Progression-Free Survival
mesh[24].qualifier_ui
mesh[24].descriptor_ui	D005260
mesh[24].is_major_topic	False
mesh[24].qualifier_name
mesh[24].descriptor_name	Female
mesh[25].qualifier_ui
mesh[25].descriptor_ui	D006801
mesh[25].is_major_topic	False
mesh[25].qualifier_name
mesh[25].descriptor_name	Humans
mesh[26].qualifier_ui
mesh[26].descriptor_ui	D000068258
mesh[26].is_major_topic	False
mesh[26].qualifier_name
mesh[26].descriptor_name	Bevacizumab
mesh[27].qualifier_ui	Q000188
mesh[27].descriptor_ui	D000077216
mesh[27].is_major_topic	False
mesh[27].qualifier_name	drug therapy
mesh[27].descriptor_name	Carcinoma, Ovarian Epithelial
mesh[28].qualifier_ui	Q000473
mesh[28].descriptor_ui	D010051
mesh[28].is_major_topic	True
mesh[28].qualifier_name	pathology
mesh[28].descriptor_name	Ovarian Neoplasms
mesh[29].qualifier_ui
mesh[29].descriptor_ui	D010793
mesh[29].is_major_topic	False
mesh[29].qualifier_name
mesh[29].descriptor_name	Phthalazines
mesh[30].qualifier_ui
mesh[30].descriptor_ui	D010879
mesh[30].is_major_topic	True
mesh[30].qualifier_name
mesh[30].descriptor_name	Piperazines
mesh[31].qualifier_ui
mesh[31].descriptor_ui	D000077982
mesh[31].is_major_topic	False
mesh[31].qualifier_name
mesh[31].descriptor_name	Progression-Free Survival
mesh[32].qualifier_ui
mesh[32].descriptor_ui	D005260
mesh[32].is_major_topic	False
mesh[32].qualifier_name
mesh[32].descriptor_name	Female
mesh[33].qualifier_ui
mesh[33].descriptor_ui	D006801
mesh[33].is_major_topic	False
mesh[33].qualifier_name
mesh[33].descriptor_name	Humans
mesh[34].qualifier_ui
mesh[34].descriptor_ui	D000068258
mesh[34].is_major_topic	False
mesh[34].qualifier_name
mesh[34].descriptor_name	Bevacizumab
mesh[35].qualifier_ui	Q000188
mesh[35].descriptor_ui	D000077216
mesh[35].is_major_topic	False
mesh[35].qualifier_name	drug therapy
mesh[35].descriptor_name	Carcinoma, Ovarian Epithelial
mesh[36].qualifier_ui	Q000473
mesh[36].descriptor_ui	D010051
mesh[36].is_major_topic	True
mesh[36].qualifier_name	pathology
mesh[36].descriptor_name	Ovarian Neoplasms
mesh[37].qualifier_ui
mesh[37].descriptor_ui	D010793
mesh[37].is_major_topic	False
mesh[37].qualifier_name
mesh[37].descriptor_name	Phthalazines
mesh[38].qualifier_ui
mesh[38].descriptor_ui	D010879
mesh[38].is_major_topic	True
mesh[38].qualifier_name
mesh[38].descriptor_name	Piperazines
mesh[39].qualifier_ui
mesh[39].descriptor_ui	D000077982
mesh[39].is_major_topic	False
mesh[39].qualifier_name
mesh[39].descriptor_name	Progression-Free Survival
mesh[40].qualifier_ui
mesh[40].descriptor_ui	D005260
mesh[40].is_major_topic	False
mesh[40].qualifier_name
mesh[40].descriptor_name	Female
mesh[41].qualifier_ui
mesh[41].descriptor_ui	D006801
mesh[41].is_major_topic	False
mesh[41].qualifier_name
mesh[41].descriptor_name	Humans
mesh[42].qualifier_ui
mesh[42].descriptor_ui	D000068258
mesh[42].is_major_topic	False
mesh[42].qualifier_name
mesh[42].descriptor_name	Bevacizumab
mesh[43].qualifier_ui	Q000188
mesh[43].descriptor_ui	D000077216
mesh[43].is_major_topic	False
mesh[43].qualifier_name	drug therapy
mesh[43].descriptor_name	Carcinoma, Ovarian Epithelial
mesh[44].qualifier_ui	Q000473
mesh[44].descriptor_ui	D010051
mesh[44].is_major_topic	True
mesh[44].qualifier_name	pathology
mesh[44].descriptor_name	Ovarian Neoplasms
mesh[45].qualifier_ui
mesh[45].descriptor_ui	D010793
mesh[45].is_major_topic	False
mesh[45].qualifier_name
mesh[45].descriptor_name	Phthalazines
mesh[46].qualifier_ui
mesh[46].descriptor_ui	D010879
mesh[46].is_major_topic	True
mesh[46].qualifier_name
mesh[46].descriptor_name	Piperazines
mesh[47].qualifier_ui
mesh[47].descriptor_ui	D000077982
mesh[47].is_major_topic	False
mesh[47].qualifier_name
mesh[47].descriptor_name	Progression-Free Survival
type	article
title	Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
biblio.issue	4
biblio.volume	34
biblio.last_page	558
biblio.first_page	550
topics[0].id	https://openalex.org/T10550
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9997000098228455
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2743
topics[0].subfield.display_name	Reproductive Medicine
topics[0].display_name	Ovarian cancer diagnosis and treatment
topics[1].id	https://openalex.org/T11914
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9995999932289124
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	PARP inhibition in cancer therapy
topics[2].id	https://openalex.org/T12477
topics[2].field.id	https://openalex.org/fields/24
topics[2].field.display_name	Immunology and Microbiology
topics[2].score	0.9519000053405762
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/2403
topics[2].subfield.display_name	Immunology
topics[2].display_name	Toxin Mechanisms and Immunotoxins
funders[0].id	https://openalex.org/F4320307770
funders[0].ror	https://ror.org/04r9x1a08
funders[0].display_name	AstraZeneca
funders[1].id	https://openalex.org/F4320307779
funders[1].ror	https://ror.org/00by1q217
funders[1].display_name	Roche
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9637140035629272
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2779962180
concepts[1].level	5
concepts[1].score	0.8528510332107544
concepts[1].wikidata	https://www.wikidata.org/wiki/Q7083106
concepts[1].display_name	Olaparib
concepts[2].id	https://openalex.org/C2777802072
concepts[2].level	3
concepts[2].score	0.833573579788208
concepts[2].wikidata	https://www.wikidata.org/wiki/Q413299
concepts[2].display_name	Bevacizumab
concepts[3].id	https://openalex.org/C2780427987
concepts[3].level	3
concepts[3].score	0.6554402709007263
concepts[3].wikidata	https://www.wikidata.org/wiki/Q172341
concepts[3].display_name	Ovarian cancer
concepts[4].id	https://openalex.org/C143998085
concepts[4].level	1
concepts[4].score	0.6400696039199829
concepts[4].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[4].display_name	Oncology
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.5890414714813232
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
concepts[6].id	https://openalex.org/C3019894029
concepts[6].level	2
concepts[6].score	0.5561940670013428
concepts[6].wikidata	https://www.wikidata.org/wiki/Q332823
concepts[6].display_name	Overall survival
concepts[7].id	https://openalex.org/C2780739268
concepts[7].level	3
concepts[7].score	0.5020978450775146
concepts[7].wikidata	https://www.wikidata.org/wiki/Q2112244
concepts[7].display_name	Progression-free survival
concepts[8].id	https://openalex.org/C2778283404
concepts[8].level	3
concepts[8].score	0.460845947265625
concepts[8].wikidata	https://www.wikidata.org/wiki/Q6736822
concepts[8].display_name	Maintenance therapy
concepts[9].id	https://openalex.org/C121608353
concepts[9].level	2
concepts[9].score	0.29531943798065186
concepts[9].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[9].display_name	Cancer
concepts[10].id	https://openalex.org/C2776694085
concepts[10].level	2
concepts[10].score	0.24413976073265076
concepts[10].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[10].display_name	Chemotherapy
concepts[11].id	https://openalex.org/C104317684
concepts[11].level	2
concepts[11].score	0.07387453317642212
concepts[11].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[11].display_name	Gene
concepts[12].id	https://openalex.org/C182979987
concepts[12].level	4
concepts[12].score	0.06381571292877197
concepts[12].wikidata	https://www.wikidata.org/wiki/Q3907241
concepts[12].display_name	Poly ADP ribose polymerase
concepts[13].id	https://openalex.org/C82381507
concepts[13].level	3
concepts[13].score	0.0
concepts[13].wikidata	https://www.wikidata.org/wiki/Q416878
concepts[13].display_name	Polymerase
concepts[14].id	https://openalex.org/C185592680
concepts[14].level	0
concepts[14].score	0.0
concepts[14].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[14].display_name	Chemistry
concepts[15].id	https://openalex.org/C55493867
concepts[15].level	1
concepts[15].score	0.0
concepts[15].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[15].display_name	Biochemistry
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9637140035629272
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/olaparib
keywords[1].score	0.8528510332107544
keywords[1].display_name	Olaparib
keywords[2].id	https://openalex.org/keywords/bevacizumab
keywords[2].score	0.833573579788208
keywords[2].display_name	Bevacizumab
keywords[3].id	https://openalex.org/keywords/ovarian-cancer
keywords[3].score	0.6554402709007263
keywords[3].display_name	Ovarian cancer
keywords[4].id	https://openalex.org/keywords/oncology
keywords[4].score	0.6400696039199829
keywords[4].display_name	Oncology
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.5890414714813232
keywords[5].display_name	Internal medicine
keywords[6].id	https://openalex.org/keywords/overall-survival
keywords[6].score	0.5561940670013428
keywords[6].display_name	Overall survival
keywords[7].id	https://openalex.org/keywords/progression-free-survival
keywords[7].score	0.5020978450775146
keywords[7].display_name	Progression-free survival
keywords[8].id	https://openalex.org/keywords/maintenance-therapy
keywords[8].score	0.460845947265625
keywords[8].display_name	Maintenance therapy
keywords[9].id	https://openalex.org/keywords/cancer
keywords[9].score	0.29531943798065186
keywords[9].display_name	Cancer
keywords[10].id	https://openalex.org/keywords/chemotherapy
keywords[10].score	0.24413976073265076
keywords[10].display_name	Chemotherapy
keywords[11].id	https://openalex.org/keywords/gene
keywords[11].score	0.07387453317642212
keywords[11].display_name	Gene
keywords[12].id	https://openalex.org/keywords/poly-adp-ribose-polymerase
keywords[12].score	0.06381571292877197
keywords[12].display_name	Poly ADP ribose polymerase
language	en
locations[0].id	doi:10.1136/ijgc-2023-004995
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S41026820
locations[0].source.issn	1048-891X, 1525-1438
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	1048-891X
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	International Journal of Gynecological Cancer
locations[0].source.host_organization	https://openalex.org/P4310319945
locations[0].source.host_organization_name	BMJ
locations[0].source.host_organization_lineage	https://openalex.org/P4310319945
locations[0].source.host_organization_lineage_names	BMJ
locations[0].license	cc-by-nc
locations[0].pdf_url	https://ijgc.bmj.com/content/ijgc/early/2023/12/21/ijgc-2023-004995.full.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	International Journal of Gynecological Cancer
locations[0].landing_page_url	https://doi.org/10.1136/ijgc-2023-004995
locations[1].id	pmid:38129136
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/38129136
locations[2].id	pmid:40229060
locations[2].is_oa	False
locations[2].source.id	https://openalex.org/S4306525036
locations[2].source.issn
locations[2].source.type	repository
locations[2].source.is_oa	False
locations[2].source.issn_l
locations[2].source.is_core	False
locations[2].source.is_in_doaj	False
locations[2].source.display_name	PubMed
locations[2].source.host_organization	https://openalex.org/I1299303238
locations[2].source.host_organization_name	National Institutes of Health
locations[2].source.host_organization_lineage	https://openalex.org/I1299303238
locations[2].license
locations[2].pdf_url
locations[2].version	publishedVersion
locations[2].raw_type
locations[2].license_id
locations[2].is_accepted	True
locations[2].is_published	True
locations[2].raw_source_name	International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
locations[2].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/40229060
locations[3].id	pmh:oai:lirias2repo.kuleuven.be:20.500.12942/734031
locations[3].is_oa	False
locations[3].source.id	https://openalex.org/S4306401954
locations[3].source.issn
locations[3].source.type	repository
locations[3].source.is_oa	False
locations[3].source.issn_l
locations[3].source.is_core	False
locations[3].source.is_in_doaj	False
locations[3].source.display_name	Lirias (KU Leuven)
locations[3].source.host_organization	https://openalex.org/I99464096
locations[3].source.host_organization_name	KU Leuven
locations[3].source.host_organization_lineage	https://openalex.org/I99464096
locations[3].license
locations[3].pdf_url
locations[3].version	acceptedVersion
locations[3].raw_type	info:eu-repo/semantics/article
locations[3].license_id
locations[3].is_accepted	True
locations[3].is_published	False
locations[3].raw_source_name
locations[3].landing_page_url	https://lirias.kuleuven.be/handle/20.500.12942/734031
locations[4].id	pmh:oai:HAL:hal-04381794v1
locations[4].is_oa	False
locations[4].source.id	https://openalex.org/S4306402512
locations[4].source.issn
locations[4].source.type	repository
locations[4].source.is_oa	False
locations[4].source.issn_l
locations[4].source.is_core	False
locations[4].source.is_in_doaj	False
locations[4].source.display_name	HAL (Le Centre pour la Communication Scientifique Directe)
locations[4].source.host_organization	https://openalex.org/I1294671590
locations[4].source.host_organization_name	Centre National de la Recherche Scientifique
locations[4].source.host_organization_lineage	https://openalex.org/I1294671590
locations[4].license
locations[4].pdf_url
locations[4].version	submittedVersion
locations[4].raw_type	Journal articles
locations[4].license_id
locations[4].is_accepted	False
locations[4].is_published	False
locations[4].raw_source_name	International Journal of Gynecological Cancer, 2023, pp.ijgc-2023-004995. ⟨10.1136/ijgc-2023-004995⟩
locations[4].landing_page_url	https://hal.science/hal-04381794
locations[5].id	pmh:oai:pubmedcentral.nih.gov:10982633
locations[5].is_oa	True
locations[5].source.id	https://openalex.org/S2764455111
locations[5].source.issn
locations[5].source.type	repository
locations[5].source.is_oa	False
locations[5].source.issn_l
locations[5].source.is_core	False
locations[5].source.is_in_doaj	False
locations[5].source.display_name	PubMed Central
locations[5].source.host_organization	https://openalex.org/I1299303238
locations[5].source.host_organization_name	National Institutes of Health
locations[5].source.host_organization_lineage	https://openalex.org/I1299303238
locations[5].license	other-oa
locations[5].pdf_url
locations[5].version	submittedVersion
locations[5].raw_type	Text
locations[5].license_id	https://openalex.org/licenses/other-oa
locations[5].is_accepted	False
locations[5].is_published	False
locations[5].raw_source_name	Int J Gynecol Cancer
locations[5].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/10982633
indexed_in	crossref, pubmed
authorships[0].author.id	https://openalex.org/A5061939825
authorships[0].author.orcid	https://orcid.org/0000-0003-0981-0598
authorships[0].author.display_name	Domenica Lorusso
authorships[0].countries	IT
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210153126
authorships[0].affiliations[0].raw_affiliation_string	Istituto Tumori Milano + Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
authorships[0].institutions[0].id	https://openalex.org/I4210153126
authorships[0].institutions[0].ror	https://ror.org/04tfzc498
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I4210153126
authorships[0].institutions[0].country_code	IT
authorships[0].institutions[0].display_name	Istituti di Ricovero e Cura a Carattere Scientifico
authorships[0].author_position	first
authorships[0].raw_author_name	Domenica Lorusso
authorships[0].is_corresponding	True
authorships[0].raw_affiliation_strings	Istituto Tumori Milano + Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
authorships[1].author.id	https://openalex.org/A5119269897
authorships[1].author.orcid	https://orcid.org/0000-0001-6981-1678
authorships[1].author.display_name	Marie‐Ange Mouret‐Reynier
authorships[1].countries	FR
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210124119
authorships[1].affiliations[0].raw_affiliation_string	Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France
authorships[1].affiliations[1].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[1].institutions[0].id	https://openalex.org/I4210124119
authorships[1].institutions[0].ror	https://ror.org/02pwnhd33
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I4210124119
authorships[1].institutions[0].country_code	FR
authorships[1].institutions[0].display_name	Centre Jean Perrin
authorships[1].author_position	middle
authorships[1].raw_author_name	Marie-Ange Mouret-Reynier
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[2].author.id	https://openalex.org/A5078567055
authorships[2].author.orcid	https://orcid.org/0000-0002-9663-5005
authorships[2].author.display_name	Philipp Harter
authorships[2].countries	DE
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210095785
authorships[2].affiliations[0].raw_affiliation_string	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany
authorships[2].affiliations[1].institution_ids	https://openalex.org/I4210146447
authorships[2].affiliations[1].raw_affiliation_string	Department of Gynaecology & Gynaecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany
authorships[2].institutions[0].id	https://openalex.org/I4210095785
authorships[2].institutions[0].ror	https://ror.org/01kjfnp05
authorships[2].institutions[0].type	nonprofit
authorships[2].institutions[0].lineage	https://openalex.org/I4210095785
authorships[2].institutions[0].country_code	DE
authorships[2].institutions[0].display_name	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
authorships[2].institutions[1].id	https://openalex.org/I4210146447
authorships[2].institutions[1].ror	https://ror.org/03v958f45
authorships[2].institutions[1].type	healthcare
authorships[2].institutions[1].lineage	https://openalex.org/I4210146447
authorships[2].institutions[1].country_code	DE
authorships[2].institutions[1].display_name	Kliniken Essen-Mitte
authorships[2].author_position	middle
authorships[2].raw_author_name	Philipp Harter
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany, Department of Gynaecology & Gynaecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany
authorships[3].author.id	https://openalex.org/A5038384830
authorships[3].author.orcid	https://orcid.org/0000-0001-9412-5952
authorships[3].author.display_name	Claire Cropet
authorships[3].countries	FR
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210105738
authorships[3].affiliations[0].raw_affiliation_string	Department of Biostatistics, Centre Léon Bérard, Lyon, France
authorships[3].institutions[0].id	https://openalex.org/I4210105738
authorships[3].institutions[0].ror	https://ror.org/01cmnjq37
authorships[3].institutions[0].type	nonprofit
authorships[3].institutions[0].lineage	https://openalex.org/I4210105738
authorships[3].institutions[0].country_code	FR
authorships[3].institutions[0].display_name	Centre Léon Bérard
authorships[3].author_position	middle
authorships[3].raw_author_name	Claire Cropet
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Department of Biostatistics, Centre Léon Bérard, Lyon, France
authorships[4].author.id	https://openalex.org/A5113035511
authorships[4].author.orcid
authorships[4].author.display_name	Cristina Caballero
authorships[4].countries	ES
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210154151
authorships[4].affiliations[0].raw_affiliation_string	Grupo Español de Investigación en Cáncer de Ovario, (GEICO), Spain
authorships[4].affiliations[1].institution_ids	https://openalex.org/I4210127649
authorships[4].affiliations[1].raw_affiliation_string	Servicio de Oncología Médica, Hospital General Universitario de Valencia, Valencia, Spain
authorships[4].institutions[0].id	https://openalex.org/I4210127649
authorships[4].institutions[0].ror	https://ror.org/03sz8rb35
authorships[4].institutions[0].type	healthcare
authorships[4].institutions[0].lineage	https://openalex.org/I4210127649
authorships[4].institutions[0].country_code	ES
authorships[4].institutions[0].display_name	Hospital General Universitario De Valencia
authorships[4].institutions[1].id	https://openalex.org/I4210154151
authorships[4].institutions[1].ror	https://ror.org/04zw2sa68
authorships[4].institutions[1].type	nonprofit
authorships[4].institutions[1].lineage	https://openalex.org/I4210154151
authorships[4].institutions[1].country_code	ES
authorships[4].institutions[1].display_name	Spanish Ovarian Cancer Research Group
authorships[4].author_position	middle
authorships[4].raw_author_name	Cristina Caballero
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Grupo Español de Investigación en Cáncer de Ovario, (GEICO), Spain, Servicio de Oncología Médica, Hospital General Universitario de Valencia, Valencia, Spain
authorships[5].author.id	https://openalex.org/A5034517809
authorships[5].author.orcid
authorships[5].author.display_name	P Wolfrum-Ristau
authorships[5].countries	AT
authorships[5].affiliations[0].institution_ids	https://openalex.org/I4210144666
authorships[5].affiliations[0].raw_affiliation_string	Arbeitsgemeinschaft Gynaekologische Onkologie Study Group, (AGO-Austria), Austria
authorships[5].affiliations[1].institution_ids	https://openalex.org/I27945538
authorships[5].affiliations[1].raw_affiliation_string	Department of Obstetrics and Gynecology, Paracelsus Medical University Salzburg, Salzburg, Austria
authorships[5].institutions[0].id	https://openalex.org/I4210144666
authorships[5].institutions[0].ror	https://ror.org/044cwq841
authorships[5].institutions[0].type	nonprofit
authorships[5].institutions[0].lineage	https://openalex.org/I4210144666
authorships[5].institutions[0].country_code	AT
authorships[5].institutions[0].display_name	AGO Austria
authorships[5].institutions[1].id	https://openalex.org/I27945538
authorships[5].institutions[1].ror	https://ror.org/03z3mg085
authorships[5].institutions[1].type	education
authorships[5].institutions[1].lineage	https://openalex.org/I27945538
authorships[5].institutions[1].country_code	AT
authorships[5].institutions[1].display_name	Paracelsus Medical University
authorships[5].author_position	middle
authorships[5].raw_author_name	Pia Wolfrum-Ristau
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Arbeitsgemeinschaft Gynaekologische Onkologie Study Group, (AGO-Austria), Austria, Department of Obstetrics and Gynecology, Paracelsus Medical University Salzburg, Salzburg, Austria
authorships[6].author.id	https://openalex.org/A5087351447
authorships[6].author.orcid	https://orcid.org/0000-0002-6929-5463
authorships[6].author.display_name	Toyomi Satoh
authorships[6].countries	JP
authorships[6].affiliations[0].raw_affiliation_string	Gynecologic Oncology Trial and Investigation Consortium, (GOTIC), Japan
authorships[6].affiliations[1].institution_ids	https://openalex.org/I146399215
authorships[6].affiliations[1].raw_affiliation_string	Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
authorships[6].institutions[0].id	https://openalex.org/I146399215
authorships[6].institutions[0].ror	https://ror.org/02956yf07
authorships[6].institutions[0].type	education
authorships[6].institutions[0].lineage	https://openalex.org/I146399215
authorships[6].institutions[0].country_code	JP
authorships[6].institutions[0].display_name	University of Tsukuba
authorships[6].author_position	middle
authorships[6].raw_author_name	Toyomi Satoh
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, Gynecologic Oncology Trial and Investigation Consortium, (GOTIC), Japan
authorships[7].author.id	https://openalex.org/A5058535647
authorships[7].author.orcid	https://orcid.org/0000-0002-7589-8981
authorships[7].author.display_name	Ignace Vergote
authorships[7].countries	BE
authorships[7].affiliations[0].institution_ids	https://openalex.org/I1320481043
authorships[7].affiliations[0].raw_affiliation_string	Department of Obstetrics and Gynaecology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union
authorships[7].affiliations[1].institution_ids	https://openalex.org/I1320481043, https://openalex.org/I4210091886
authorships[7].affiliations[1].raw_affiliation_string	Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Belgium, European Union
authorships[7].institutions[0].id	https://openalex.org/I1320481043
authorships[7].institutions[0].ror	https://ror.org/019w4f821
authorships[7].institutions[0].type	government
authorships[7].institutions[0].lineage	https://openalex.org/I1320481043
authorships[7].institutions[0].country_code	BE
authorships[7].institutions[0].display_name	European Union
authorships[7].institutions[1].id	https://openalex.org/I4210091886
authorships[7].institutions[1].ror	https://ror.org/00cfkaw62
authorships[7].institutions[1].type	nonprofit
authorships[7].institutions[1].lineage	https://openalex.org/I4210091886
authorships[7].institutions[1].country_code	BE
authorships[7].institutions[1].display_name	The European Academy of Gynaecological Surgery
authorships[7].author_position	middle
authorships[7].raw_author_name	Ignace Vergote
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Belgium, European Union, Department of Obstetrics and Gynaecology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union
authorships[8].author.id	https://openalex.org/A5111912022
authorships[8].author.orcid	https://orcid.org/0000-0002-2150-0448
authorships[8].author.display_name	Gabriella Parma
authorships[8].countries	IT
authorships[8].affiliations[0].raw_affiliation_string	Mario Negri Gynecologic Oncology Group, (MANGO), Italy
authorships[8].affiliations[1].institution_ids	https://openalex.org/I6141010
authorships[8].affiliations[1].raw_affiliation_string	Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, Italy
authorships[8].institutions[0].id	https://openalex.org/I6141010
authorships[8].institutions[0].ror	https://ror.org/02vr0ne26
authorships[8].institutions[0].type	healthcare
authorships[8].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I6141010
authorships[8].institutions[0].country_code	IT
authorships[8].institutions[0].display_name	European Institute of Oncology
authorships[8].author_position	middle
authorships[8].raw_author_name	Gabriella Parma
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, Italy, Mario Negri Gynecologic Oncology Group, (MANGO), Italy
authorships[9].author.id	https://openalex.org/A5111040359
authorships[9].author.orcid
authorships[9].author.display_name	Trine Jakobi Nøttrup
authorships[9].countries	DK
authorships[9].affiliations[0].institution_ids	https://openalex.org/I4210087227
authorships[9].affiliations[0].raw_affiliation_string	Nordic Society of Gynecologic Oncology, (NSGO), Denmark
authorships[9].affiliations[1].institution_ids	https://openalex.org/I2802567020, https://openalex.org/I2802709434
authorships[9].affiliations[1].raw_affiliation_string	Department of Oncology, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
authorships[9].institutions[0].id	https://openalex.org/I2802567020
authorships[9].institutions[0].ror	https://ror.org/05bpbnx46
authorships[9].institutions[0].type	healthcare
authorships[9].institutions[0].lineage	https://openalex.org/I2802567020
authorships[9].institutions[0].country_code	DK
authorships[9].institutions[0].display_name	Copenhagen University Hospital
authorships[9].institutions[1].id	https://openalex.org/I4210087227
authorships[9].institutions[1].ror	https://ror.org/004v35q61
authorships[9].institutions[1].type	nonprofit
authorships[9].institutions[1].lineage	https://openalex.org/I4210087227
authorships[9].institutions[1].country_code	DK
authorships[9].institutions[1].display_name	Nordic Society of Gynecologic Oncology
authorships[9].institutions[2].id	https://openalex.org/I2802709434
authorships[9].institutions[2].ror	https://ror.org/03mchdq19
authorships[9].institutions[2].type	healthcare
authorships[9].institutions[2].lineage	https://openalex.org/I2802567020, https://openalex.org/I2802709434, https://openalex.org/I4210145385
authorships[9].institutions[2].country_code	DK
authorships[9].institutions[2].display_name	Rigshospitalet
authorships[9].author_position	middle
authorships[9].raw_author_name	Trine J Nøttrup
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	Department of Oncology, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark, Nordic Society of Gynecologic Oncology, (NSGO), Denmark
authorships[10].author.id	https://openalex.org/A5023971145
authorships[10].author.orcid	https://orcid.org/0000-0002-4275-1721
authorships[10].author.display_name	Coriolan Lebreton
authorships[10].countries	FR
authorships[10].affiliations[0].institution_ids	https://openalex.org/I4210134409
authorships[10].affiliations[0].raw_affiliation_string	Department of Medical Oncology, Institut Bergonié, Bordeaux, France
authorships[10].affiliations[1].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[10].institutions[0].id	https://openalex.org/I4210134409
authorships[10].institutions[0].ror	https://ror.org/02yw1f353
authorships[10].institutions[0].type	healthcare
authorships[10].institutions[0].lineage	https://openalex.org/I4210134409
authorships[10].institutions[0].country_code	FR
authorships[10].institutions[0].display_name	Institut Bergonié
authorships[10].author_position	middle
authorships[10].raw_author_name	Coriolan Lebreton
authorships[10].is_corresponding	False
authorships[10].raw_affiliation_strings	Department of Medical Oncology, Institut Bergonié, Bordeaux, France, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[11].author.id	https://openalex.org/A5108888148
authorships[11].author.orcid
authorships[11].author.display_name	Peter A. Fasching
authorships[11].countries	DE
authorships[11].affiliations[0].institution_ids	https://openalex.org/I4210088053
authorships[11].affiliations[0].raw_affiliation_string	Gynecology and Obstetrics Translational Medicine, Universitätsfrauenklinik Erlangen, Erlangen, Germany
authorships[11].affiliations[1].institution_ids	https://openalex.org/I4210095785
authorships[11].affiliations[1].raw_affiliation_string	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany
authorships[11].institutions[0].id	https://openalex.org/I4210095785
authorships[11].institutions[0].ror	https://ror.org/01kjfnp05
authorships[11].institutions[0].type	nonprofit
authorships[11].institutions[0].lineage	https://openalex.org/I4210095785
authorships[11].institutions[0].country_code	DE
authorships[11].institutions[0].display_name	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
authorships[11].institutions[1].id	https://openalex.org/I4210088053
authorships[11].institutions[1].ror	https://ror.org/0030f2a11
authorships[11].institutions[1].type	healthcare
authorships[11].institutions[1].lineage	https://openalex.org/I4210088053
authorships[11].institutions[1].country_code	DE
authorships[11].institutions[1].display_name	Universitätsklinikum Erlangen
authorships[11].author_position	middle
authorships[11].raw_author_name	Peter A Fasching
authorships[11].is_corresponding	False
authorships[11].raw_affiliation_strings	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany, Gynecology and Obstetrics Translational Medicine, Universitätsfrauenklinik Erlangen, Erlangen, Germany
authorships[12].author.id	https://openalex.org/A5030595144
authorships[12].author.orcid	https://orcid.org/0000-0003-4577-6534
authorships[12].author.display_name	Carmela Pisano
authorships[12].countries	IT
authorships[12].affiliations[0].institution_ids	https://openalex.org/I4210127391
authorships[12].affiliations[0].raw_affiliation_string	Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies, (MITO), Italy
authorships[12].affiliations[1].institution_ids	https://openalex.org/I4210141868
authorships[12].affiliations[1].raw_affiliation_string	Department of Urology and Gynecology, Istituto Nazionale Tumori, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-Fondazione G. Pascale Napoli, Naples, Italy
authorships[12].institutions[0].id	https://openalex.org/I4210141868
authorships[12].institutions[0].ror	https://ror.org/0506y2b23
authorships[12].institutions[0].type	healthcare
authorships[12].institutions[0].lineage	https://openalex.org/I4210141868, https://openalex.org/I4210153126
authorships[12].institutions[0].country_code	IT
authorships[12].institutions[0].display_name	Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
authorships[12].institutions[1].id	https://openalex.org/I4210127391
authorships[12].institutions[1].ror	https://ror.org/02g2x7380
authorships[12].institutions[1].type	nonprofit
authorships[12].institutions[1].lineage	https://openalex.org/I4210127391
authorships[12].institutions[1].country_code	IT
authorships[12].institutions[1].display_name	Italian Association for Cancer Research
authorships[12].author_position	middle
authorships[12].raw_author_name	Carmela Pisano
authorships[12].is_corresponding	False
authorships[12].raw_affiliation_strings	Department of Urology and Gynecology, Istituto Nazionale Tumori, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-Fondazione G. Pascale Napoli, Naples, Italy, Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies, (MITO), Italy
authorships[13].author.id	https://openalex.org/A5042084238
authorships[13].author.orcid	https://orcid.org/0000-0002-1683-550X
authorships[13].author.display_name	Luís Manso
authorships[13].countries	ES
authorships[13].affiliations[0].institution_ids	https://openalex.org/I4210086614
authorships[13].affiliations[0].raw_affiliation_string	Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain
authorships[13].affiliations[1].institution_ids	https://openalex.org/I4210154151
authorships[13].affiliations[1].raw_affiliation_string	Grupo Español de Investigación en Cáncer de Ovario, (GEICO), Spain
authorships[13].institutions[0].id	https://openalex.org/I4210086614
authorships[13].institutions[0].ror	https://ror.org/002x1sg85
authorships[13].institutions[0].type	healthcare
authorships[13].institutions[0].lineage	https://openalex.org/I4210086614
authorships[13].institutions[0].country_code	ES
authorships[13].institutions[0].display_name	Research Institute Hospital 12 de Octubre
authorships[13].institutions[1].id	https://openalex.org/I4210154151
authorships[13].institutions[1].ror	https://ror.org/04zw2sa68
authorships[13].institutions[1].type	nonprofit
authorships[13].institutions[1].lineage	https://openalex.org/I4210154151
authorships[13].institutions[1].country_code	ES
authorships[13].institutions[1].display_name	Spanish Ovarian Cancer Research Group
authorships[13].author_position	middle
authorships[13].raw_author_name	Luis Manso
authorships[13].is_corresponding	False
authorships[13].raw_affiliation_strings	Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain, Grupo Español de Investigación en Cáncer de Ovario, (GEICO), Spain
authorships[14].author.id	https://openalex.org/A5021197091
authorships[14].author.orcid	https://orcid.org/0000-0001-6682-4916
authorships[14].author.display_name	Hugues Bourgeois
authorships[14].countries	FR
authorships[14].affiliations[0].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[14].affiliations[1].institution_ids	https://openalex.org/I4210123491, https://openalex.org/I4210135187
authorships[14].affiliations[1].raw_affiliation_string	Medical Oncology Department, Centre Jean Bernard – Clinique Victor Hugo, Le Mans, France
authorships[14].institutions[0].id	https://openalex.org/I4210123491
authorships[14].institutions[0].ror	https://ror.org/02s2qzh96
authorships[14].institutions[0].type	healthcare
authorships[14].institutions[0].lineage	https://openalex.org/I4210123491
authorships[14].institutions[0].country_code	FR
authorships[14].institutions[0].display_name	Centre Jean Bernard
authorships[14].institutions[1].id	https://openalex.org/I4210135187
authorships[14].institutions[1].ror	https://ror.org/04qvenw96
authorships[14].institutions[1].type	healthcare
authorships[14].institutions[1].lineage	https://openalex.org/I4210135187
authorships[14].institutions[1].country_code	FR
authorships[14].institutions[1].display_name	Clinique Victor Hugo
authorships[14].author_position	middle
authorships[14].raw_author_name	Hugues Bourgeois
authorships[14].is_corresponding	False
authorships[14].raw_affiliation_strings	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France, Medical Oncology Department, Centre Jean Bernard – Clinique Victor Hugo, Le Mans, France
authorships[15].author.id	https://openalex.org/A5007674739
authorships[15].author.orcid	https://orcid.org/0000-0002-6702-4651
authorships[15].author.display_name	Ingo B. Runnebaum
authorships[15].countries	DE
authorships[15].affiliations[0].institution_ids	https://openalex.org/I4210134900, https://openalex.org/I76198965
authorships[15].affiliations[0].raw_affiliation_string	Department of Gynecology and Reproductive Medicine, Jena University Hospital, Friedrich Schiller University, Jena, Germany
authorships[15].affiliations[1].institution_ids	https://openalex.org/I4210095785
authorships[15].affiliations[1].raw_affiliation_string	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany
authorships[15].institutions[0].id	https://openalex.org/I4210095785
authorships[15].institutions[0].ror	https://ror.org/01kjfnp05
authorships[15].institutions[0].type	nonprofit
authorships[15].institutions[0].lineage	https://openalex.org/I4210095785
authorships[15].institutions[0].country_code	DE
authorships[15].institutions[0].display_name	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
authorships[15].institutions[1].id	https://openalex.org/I76198965
authorships[15].institutions[1].ror	https://ror.org/05qpz1x62
authorships[15].institutions[1].type	education
authorships[15].institutions[1].lineage	https://openalex.org/I76198965
authorships[15].institutions[1].country_code	DE
authorships[15].institutions[1].display_name	Friedrich Schiller University Jena
authorships[15].institutions[2].id	https://openalex.org/I4210134900
authorships[15].institutions[2].ror	https://ror.org/035rzkx15
authorships[15].institutions[2].type	healthcare
authorships[15].institutions[2].lineage	https://openalex.org/I4210134900
authorships[15].institutions[2].country_code	DE
authorships[15].institutions[2].display_name	Jena University Hospital
authorships[15].author_position	middle
authorships[15].raw_author_name	Ingo Runnebaum
authorships[15].is_corresponding	False
authorships[15].raw_affiliation_strings	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany, Department of Gynecology and Reproductive Medicine, Jena University Hospital, Friedrich Schiller University, Jena, Germany
authorships[16].author.id	https://openalex.org/A5018118709
authorships[16].author.orcid	https://orcid.org/0000-0003-0052-2581
authorships[16].author.display_name	Claudio Zamagni
authorships[16].countries	IT
authorships[16].affiliations[0].institution_ids	https://openalex.org/I4210127391
authorships[16].affiliations[0].raw_affiliation_string	Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies, (MITO), Italy
authorships[16].affiliations[1].institution_ids	https://openalex.org/I4210119117
authorships[16].affiliations[1].raw_affiliation_string	IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy
authorships[16].institutions[0].id	https://openalex.org/I4210119117
authorships[16].institutions[0].ror	https://ror.org/02mby1820
authorships[16].institutions[0].type	healthcare
authorships[16].institutions[0].lineage	https://openalex.org/I4210119117
authorships[16].institutions[0].country_code	IT
authorships[16].institutions[0].display_name	Azienda USL di Bologna
authorships[16].institutions[1].id	https://openalex.org/I4210127391
authorships[16].institutions[1].ror	https://ror.org/02g2x7380
authorships[16].institutions[1].type	nonprofit
authorships[16].institutions[1].lineage	https://openalex.org/I4210127391
authorships[16].institutions[1].country_code	IT
authorships[16].institutions[1].display_name	Italian Association for Cancer Research
authorships[16].author_position	middle
authorships[16].raw_author_name	Claudio Zamagni
authorships[16].is_corresponding	False
authorships[16].raw_affiliation_strings	IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy, Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies, (MITO), Italy
authorships[17].author.id	https://openalex.org/A5018378577
authorships[17].author.orcid	https://orcid.org/0000-0001-5388-4362
authorships[17].author.display_name	Anne‐Claire Hardy‐Bessard
authorships[17].affiliations[0].raw_affiliation_string	Oncologie Médicale, Centre CARIO - HPCA, Plérin Sur Mer, Plérin, France
authorships[17].affiliations[1].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[17].author_position	middle
authorships[17].raw_author_name	Anne-Claire Hardy-Bessard
authorships[17].is_corresponding	False
authorships[17].raw_affiliation_strings	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France, Oncologie Médicale, Centre CARIO - HPCA, Plérin Sur Mer, Plérin, France
authorships[18].author.id	https://openalex.org/A5051947787
authorships[18].author.orcid	https://orcid.org/0000-0002-5410-3561
authorships[18].author.display_name	Andreas Schnelzer
authorships[18].countries	DE
authorships[18].affiliations[0].institution_ids	https://openalex.org/I2802619606, https://openalex.org/I62916508
authorships[18].affiliations[0].raw_affiliation_string	Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany
authorships[18].affiliations[1].institution_ids	https://openalex.org/I4210095785
authorships[18].affiliations[1].raw_affiliation_string	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany
authorships[18].institutions[0].id	https://openalex.org/I4210095785
authorships[18].institutions[0].ror	https://ror.org/01kjfnp05
authorships[18].institutions[0].type	nonprofit
authorships[18].institutions[0].lineage	https://openalex.org/I4210095785
authorships[18].institutions[0].country_code	DE
authorships[18].institutions[0].display_name	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
authorships[18].institutions[1].id	https://openalex.org/I2802619606
authorships[18].institutions[1].ror	https://ror.org/04jc43x05
authorships[18].institutions[1].type	healthcare
authorships[18].institutions[1].lineage	https://openalex.org/I2802619606, https://openalex.org/I62916508
authorships[18].institutions[1].country_code	DE
authorships[18].institutions[1].display_name	Klinikum rechts der Isar
authorships[18].institutions[2].id	https://openalex.org/I62916508
authorships[18].institutions[2].ror	https://ror.org/02kkvpp62
authorships[18].institutions[2].type	education
authorships[18].institutions[2].lineage	https://openalex.org/I62916508
authorships[18].institutions[2].country_code	DE
authorships[18].institutions[2].display_name	Technical University of Munich
authorships[18].author_position	middle
authorships[18].raw_author_name	Andreas Schnelzer
authorships[18].is_corresponding	False
authorships[18].raw_affiliation_strings	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany, Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany
authorships[19].author.id	https://openalex.org/A5086083902
authorships[19].author.orcid	https://orcid.org/0000-0003-1910-4777
authorships[19].author.display_name	Michel Fabbro
authorships[19].countries	FR
authorships[19].affiliations[0].institution_ids	https://openalex.org/I4210140335
authorships[19].affiliations[0].raw_affiliation_string	Institut du Cancer de Montpellier, Montpellier, France
authorships[19].affiliations[1].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[19].institutions[0].id	https://openalex.org/I4210140335
authorships[19].institutions[0].ror	https://ror.org/03capj968
authorships[19].institutions[0].type	facility
authorships[19].institutions[0].lineage	https://openalex.org/I154526488, https://openalex.org/I19894307, https://openalex.org/I4210140335, https://openalex.org/I4210141925, https://openalex.org/I4387154388
authorships[19].institutions[0].country_code	FR
authorships[19].institutions[0].display_name	Institut de Recherche en Cancérologie de Montpellier
authorships[19].author_position	middle
authorships[19].raw_author_name	Michel Fabbro
authorships[19].is_corresponding	False
authorships[19].raw_affiliation_strings	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France, Institut du Cancer de Montpellier, Montpellier, France
authorships[20].author.id	https://openalex.org/A5071055386
authorships[20].author.orcid	https://orcid.org/0000-0001-8142-2915
authorships[20].author.display_name	Barbara Schmalfeldt
authorships[20].countries	DE
authorships[20].affiliations[0].institution_ids	https://openalex.org/I159176309, https://openalex.org/I4210108711
authorships[20].affiliations[0].raw_affiliation_string	Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
authorships[20].affiliations[1].institution_ids	https://openalex.org/I4210095785
authorships[20].affiliations[1].raw_affiliation_string	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany
authorships[20].institutions[0].id	https://openalex.org/I4210095785
authorships[20].institutions[0].ror	https://ror.org/01kjfnp05
authorships[20].institutions[0].type	nonprofit
authorships[20].institutions[0].lineage	https://openalex.org/I4210095785
authorships[20].institutions[0].country_code	DE
authorships[20].institutions[0].display_name	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
authorships[20].institutions[1].id	https://openalex.org/I4210108711
authorships[20].institutions[1].ror	https://ror.org/01zgy1s35
authorships[20].institutions[1].type	healthcare
authorships[20].institutions[1].lineage	https://openalex.org/I159176309, https://openalex.org/I4210108711
authorships[20].institutions[1].country_code	DE
authorships[20].institutions[1].display_name	University Medical Center Hamburg-Eppendorf
authorships[20].institutions[2].id	https://openalex.org/I159176309
authorships[20].institutions[2].ror	https://ror.org/00g30e956
authorships[20].institutions[2].type	education
authorships[20].institutions[2].lineage	https://openalex.org/I159176309
authorships[20].institutions[2].country_code	DE
authorships[20].institutions[2].display_name	Universität Hamburg
authorships[20].author_position	middle
authorships[20].raw_author_name	Barbara Schmalfeldt
authorships[20].is_corresponding	False
authorships[20].raw_affiliation_strings	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
authorships[21].author.id	https://openalex.org/A5034544552
authorships[21].author.orcid
authorships[21].author.display_name	Dominique Berton
authorships[21].countries	FR
authorships[21].affiliations[0].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[21].affiliations[1].institution_ids	https://openalex.org/I4210106090
authorships[21].affiliations[1].raw_affiliation_string	L'Institut de Cancérologie de l'Ouest (ICO), Centre René Gauducheau, Saint Herblain, France
authorships[21].institutions[0].id	https://openalex.org/I4210106090
authorships[21].institutions[0].ror	https://ror.org/01m6as704
authorships[21].institutions[0].type	healthcare
authorships[21].institutions[0].lineage	https://openalex.org/I4210106090
authorships[21].institutions[0].country_code	FR
authorships[21].institutions[0].display_name	Institut de Cancérologie de l'Ouest
authorships[21].author_position	middle
authorships[21].raw_author_name	Dominique Berton
authorships[21].is_corresponding	False
authorships[21].raw_affiliation_strings	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France, L'Institut de Cancérologie de l'Ouest (ICO), Centre René Gauducheau, Saint Herblain, France
authorships[22].author.id	https://openalex.org/A5084015382
authorships[22].author.orcid	https://orcid.org/0000-0003-3549-1156
authorships[22].author.display_name	Antje Belau
authorships[22].countries	DE
authorships[22].affiliations[0].institution_ids	https://openalex.org/I4210122374
authorships[22].affiliations[0].raw_affiliation_string	Universitätsmedizin Greifswald, Frauenklinik & Frauenarztpraxis, Greifswald, Germany
authorships[22].affiliations[1].institution_ids	https://openalex.org/I4210095785
authorships[22].affiliations[1].raw_affiliation_string	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany
authorships[22].institutions[0].id	https://openalex.org/I4210095785
authorships[22].institutions[0].ror	https://ror.org/01kjfnp05
authorships[22].institutions[0].type	nonprofit
authorships[22].institutions[0].lineage	https://openalex.org/I4210095785
authorships[22].institutions[0].country_code	DE
authorships[22].institutions[0].display_name	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
authorships[22].institutions[1].id	https://openalex.org/I4210122374
authorships[22].institutions[1].ror	https://ror.org/02veq1j93
authorships[22].institutions[1].type	healthcare
authorships[22].institutions[1].lineage	https://openalex.org/I4210094118, https://openalex.org/I4210122374
authorships[22].institutions[1].country_code	DE
authorships[22].institutions[1].display_name	Universitäts Frauenklinik
authorships[22].author_position	middle
authorships[22].raw_author_name	Antje Belau
authorships[22].is_corresponding	False
authorships[22].raw_affiliation_strings	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany, Universitätsmedizin Greifswald, Frauenklinik & Frauenarztpraxis, Greifswald, Germany
authorships[23].author.id	https://openalex.org/A5012976258
authorships[23].author.orcid	https://orcid.org/0000-0003-1771-7051
authorships[23].author.display_name	Jean‐Pierre Lotz
authorships[23].countries	FR
authorships[23].affiliations[0].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[23].affiliations[1].institution_ids	https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210166768
authorships[23].affiliations[1].raw_affiliation_string	Hôpital Tenon, APHP, Paris, France
authorships[23].institutions[0].id	https://openalex.org/I4210097159
authorships[23].institutions[0].ror	https://ror.org/00pg5jh14
authorships[23].institutions[0].type	healthcare
authorships[23].institutions[0].lineage	https://openalex.org/I4210097159
authorships[23].institutions[0].country_code	FR
authorships[23].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[23].institutions[1].id	https://openalex.org/I4210166768
authorships[23].institutions[1].ror	https://ror.org/05h5v3c50
authorships[23].institutions[1].type	healthcare
authorships[23].institutions[1].lineage	https://openalex.org/I4210166768
authorships[23].institutions[1].country_code	FR
authorships[23].institutions[1].display_name	Hôpital Tenon
authorships[23].institutions[2].id	https://openalex.org/I39804081
authorships[23].institutions[2].ror	https://ror.org/02en5vm52
authorships[23].institutions[2].type	education
authorships[23].institutions[2].lineage	https://openalex.org/I39804081
authorships[23].institutions[2].country_code	FR
authorships[23].institutions[2].display_name	Sorbonne Université
authorships[23].author_position	middle
authorships[23].raw_author_name	Jean-Pierre Lotz
authorships[23].is_corresponding	False
authorships[23].raw_affiliation_strings	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France, Hôpital Tenon, APHP, Paris, France
authorships[24].author.id	https://openalex.org/A5087365172
authorships[24].author.orcid
authorships[24].author.display_name	Martina Gropp‐Meier
authorships[24].countries	DE
authorships[24].affiliations[0].institution_ids	https://openalex.org/I4210095785
authorships[24].affiliations[0].raw_affiliation_string	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany
authorships[24].affiliations[1].institution_ids	https://openalex.org/I4210097841
authorships[24].affiliations[1].raw_affiliation_string	Onkologie Ravensburg, Ravensburg, Germany
authorships[24].institutions[0].id	https://openalex.org/I4210095785
authorships[24].institutions[0].ror	https://ror.org/01kjfnp05
authorships[24].institutions[0].type	nonprofit
authorships[24].institutions[0].lineage	https://openalex.org/I4210095785
authorships[24].institutions[0].country_code	DE
authorships[24].institutions[0].display_name	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
authorships[24].institutions[1].id	https://openalex.org/I4210097841
authorships[24].institutions[1].ror	https://ror.org/014cnmj57
authorships[24].institutions[1].type	education
authorships[24].institutions[1].lineage	https://openalex.org/I4210097841
authorships[24].institutions[1].country_code	DE
authorships[24].institutions[1].display_name	Ravensburg University of Cooperative Education
authorships[24].author_position	middle
authorships[24].raw_author_name	Martina Gropp-Meier
authorships[24].is_corresponding	False
authorships[24].raw_affiliation_strings	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany, Onkologie Ravensburg, Ravensburg, Germany
authorships[25].author.id	https://openalex.org/A5006619822
authorships[25].author.orcid	https://orcid.org/0000-0002-6980-9719
authorships[25].author.display_name	Laurence Gladieff
authorships[25].countries	FR
authorships[25].affiliations[0].institution_ids	https://openalex.org/I4210128666
authorships[25].affiliations[0].raw_affiliation_string	Oncopole CLAUDIUS REGAUD IUCT-Oncopole, Toulouse, France
authorships[25].affiliations[1].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[25].institutions[0].id	https://openalex.org/I4210128666
authorships[25].institutions[0].ror	https://ror.org/03pa87f90
authorships[25].institutions[0].type	healthcare
authorships[25].institutions[0].lineage	https://openalex.org/I4210128666
authorships[25].institutions[0].country_code	FR
authorships[25].institutions[0].display_name	Institut Claudius Regaud
authorships[25].author_position	middle
authorships[25].raw_author_name	Laurence Gladieff
authorships[25].is_corresponding	False
authorships[25].raw_affiliation_strings	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France, Oncopole CLAUDIUS REGAUD IUCT-Oncopole, Toulouse, France
authorships[26].author.id	https://openalex.org/A5066710773
authorships[26].author.orcid	https://orcid.org/0009-0009-5814-4334
authorships[26].author.display_name	Hans‐Joachim Lück
authorships[26].countries	DE
authorships[26].affiliations[0].institution_ids	https://openalex.org/I4210095785
authorships[26].affiliations[0].raw_affiliation_string	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany
authorships[26].affiliations[1].raw_affiliation_string	Gynäkologisch-Onkologische Praxis, Hannover, Germany
authorships[26].institutions[0].id	https://openalex.org/I4210095785
authorships[26].institutions[0].ror	https://ror.org/01kjfnp05
authorships[26].institutions[0].type	nonprofit
authorships[26].institutions[0].lineage	https://openalex.org/I4210095785
authorships[26].institutions[0].country_code	DE
authorships[26].institutions[0].display_name	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
authorships[26].author_position	middle
authorships[26].raw_author_name	Hans-Joachim Lück
authorships[26].is_corresponding	False
authorships[26].raw_affiliation_strings	Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany, Gynäkologisch-Onkologische Praxis, Hannover, Germany
authorships[27].author.id	https://openalex.org/A5040171322
authorships[27].author.orcid
authorships[27].author.display_name	Sophie Abadie‐Lacourtoisie
authorships[27].affiliations[0].raw_affiliation_string	ICO Paul Papin, Angers, France
authorships[27].affiliations[1].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[27].author_position	middle
authorships[27].raw_author_name	Sophie Abadie-Lacourtoisie
authorships[27].is_corresponding	False
authorships[27].raw_affiliation_strings	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France, ICO Paul Papin, Angers, France
authorships[28].author.id	https://openalex.org/A5073063132
authorships[28].author.orcid	https://orcid.org/0000-0002-0759-7263
authorships[28].author.display_name	Éric Pujade-Lauraine
authorships[28].countries	FR
authorships[28].affiliations[0].institution_ids	https://openalex.org/I4210134629
authorships[28].affiliations[0].raw_affiliation_string	Medical Oncology Department, ARCAGY Research, Paris, France
authorships[28].affiliations[1].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[28].institutions[0].id	https://openalex.org/I4210134629
authorships[28].institutions[0].ror	https://ror.org/03mzxvt76
authorships[28].institutions[0].type	nonprofit
authorships[28].institutions[0].lineage	https://openalex.org/I4210134629
authorships[28].institutions[0].country_code	FR
authorships[28].institutions[0].display_name	Arcagy Gineco
authorships[28].author_position	middle
authorships[28].raw_author_name	Eric Pujade-Lauraine
authorships[28].is_corresponding	False
authorships[28].raw_affiliation_strings	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France, Medical Oncology Department, ARCAGY Research, Paris, France
authorships[29].author.id	https://openalex.org/A5073713547
authorships[29].author.orcid	https://orcid.org/0000-0003-2472-8306
authorships[29].author.display_name	Isabelle Ray‐Coquard
authorships[29].countries	FR
authorships[29].affiliations[0].raw_affiliation_string	Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
authorships[29].affiliations[1].institution_ids	https://openalex.org/I4210105738
authorships[29].affiliations[1].raw_affiliation_string	Department of Medical Oncology, Centre Léon Berard, Lyon, France
authorships[29].institutions[0].id	https://openalex.org/I4210105738
authorships[29].institutions[0].ror	https://ror.org/01cmnjq37
authorships[29].institutions[0].type	nonprofit
authorships[29].institutions[0].lineage	https://openalex.org/I4210105738
authorships[29].institutions[0].country_code	FR
authorships[29].institutions[0].display_name	Centre Léon Bérard
authorships[29].author_position	last
authorships[29].raw_author_name	Isabelle Ray-Coquard
authorships[29].is_corresponding	False
authorships[29].raw_affiliation_strings	Department of Medical Oncology, Centre Léon Berard, Lyon, France, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://ijgc.bmj.com/content/ijgc/early/2023/12/21/ijgc-2023-004995.full.pdf
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10550
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9997000098228455
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2743
primary_topic.subfield.display_name	Reproductive Medicine
primary_topic.display_name	Ovarian cancer diagnosis and treatment
related_works	https://openalex.org/W3040348061, https://openalex.org/W3002032198, https://openalex.org/W4206896499, https://openalex.org/W3082345023, https://openalex.org/W2987285665, https://openalex.org/W2235705558, https://openalex.org/W2006600283, https://openalex.org/W3000091075, https://openalex.org/W2343050467, https://openalex.org/W2308980749
cited_by_count	42
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	31
counts_by_year[1].year	2024
counts_by_year[1].cited_by_count	11
locations_count	6
best_oa_location.id	doi:10.1136/ijgc-2023-004995
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S41026820
best_oa_location.source.issn	1048-891X, 1525-1438
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	1048-891X
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	International Journal of Gynecological Cancer
best_oa_location.source.host_organization	https://openalex.org/P4310319945
best_oa_location.source.host_organization_name	BMJ
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310319945
best_oa_location.source.host_organization_lineage_names	BMJ
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url	https://ijgc.bmj.com/content/ijgc/early/2023/12/21/ijgc-2023-004995.full.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	International Journal of Gynecological Cancer
best_oa_location.landing_page_url	https://doi.org/10.1136/ijgc-2023-004995
primary_location.id	doi:10.1136/ijgc-2023-004995
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S41026820
primary_location.source.issn	1048-891X, 1525-1438
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	1048-891X
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	International Journal of Gynecological Cancer
primary_location.source.host_organization	https://openalex.org/P4310319945
primary_location.source.host_organization_name	BMJ
primary_location.source.host_organization_lineage	https://openalex.org/P4310319945
primary_location.source.host_organization_lineage_names	BMJ
primary_location.license	cc-by-nc
primary_location.pdf_url	https://ijgc.bmj.com/content/ijgc/early/2023/12/21/ijgc-2023-004995.full.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	International Journal of Gynecological Cancer
primary_location.landing_page_url	https://doi.org/10.1136/ijgc-2023-004995
publication_date	2023-12-22
publication_year	2023
referenced_works	https://openalex.org/W2162645859, https://openalex.org/W1964736695, https://openalex.org/W2994977341, https://openalex.org/W4377115689, https://openalex.org/W2102306754, https://openalex.org/W4200096254, https://openalex.org/W2034673450, https://openalex.org/W2411778206, https://openalex.org/W2019607817, https://openalex.org/W1979816698, https://openalex.org/W2053974737, https://openalex.org/W2951714360, https://openalex.org/W3208204329, https://openalex.org/W4295817627, https://openalex.org/W2975141952, https://openalex.org/W4367845062, https://openalex.org/W4281666355, https://openalex.org/W4379662245, https://openalex.org/W3204360130, https://openalex.org/W2946983074, https://openalex.org/W3217140412, https://openalex.org/W4281758300, https://openalex.org/W4388452770, https://openalex.org/W4226283539
referenced_works_count	24
abstract_inverted_index.an	41
abstract_inverted_index.at	26
abstract_inverted_index.be	21
abstract_inverted_index.in	6, 50
abstract_inverted_index.of	29
abstract_inverted_index.to	23
abstract_inverted_index.and	39
abstract_inverted_index.for	44
abstract_inverted_index.not	20
abstract_inverted_index.This	0
abstract_inverted_index.cure	45
abstract_inverted_index.plus	17
abstract_inverted_index.risk	28
abstract_inverted_index.that	5
abstract_inverted_index.with	8, 46
abstract_inverted_index.newly	9
abstract_inverted_index.rates	35
abstract_inverted_index.those	24
abstract_inverted_index.higher	27
abstract_inverted_index.should	19
abstract_inverted_index.<i>post	1
abstract_inverted_index.benefit	48
abstract_inverted_index.cancer,	14
abstract_inverted_index.disease	30
abstract_inverted_index.hoc</i>	2
abstract_inverted_index.limited	22
abstract_inverted_index.ovarian	13
abstract_inverted_index.suggest	40
abstract_inverted_index.support	36
abstract_inverted_index.advanced	11
abstract_inverted_index.analysis	3
abstract_inverted_index.olaparib	16
abstract_inverted_index.patients	7
abstract_inverted_index.survival	34
abstract_inverted_index.Five-year	32
abstract_inverted_index.diagnosed	10
abstract_inverted_index.increased	42
abstract_inverted_index.indicates	4
abstract_inverted_index.long-term	37
abstract_inverted_index.patients.	53
abstract_inverted_index.potential	43
abstract_inverted_index.remission	38
abstract_inverted_index.suggested	49
abstract_inverted_index.considered	25
abstract_inverted_index.lower-risk	51
abstract_inverted_index.particular	47
abstract_inverted_index.bevacizumab	18
abstract_inverted_index.maintenance	15
abstract_inverted_index.HRD-positive	12, 52
abstract_inverted_index.progression.	31
abstract_inverted_index.progression-free	33
cited_by_percentile_year.max	100
cited_by_percentile_year.min	99
corresponding_author_ids	https://openalex.org/A5061939825
countries_distinct_count	8
institutions_distinct_count	30
corresponding_institution_ids	https://openalex.org/I4210153126
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.7799999713897705
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.99164524
citation_normalized_percentile.is_in_top_1_percent	True
citation_normalized_percentile.is_in_top_10_percent	True